Toggle navigation
Home
Search
Services
Blog
Contact
About
Synthesis of Pluramycin, an Antitumor Antibiotic Agent
Chen, Xinhai
University of Texas Austin, Austin, TX, United States
Search grants from Xinhai Chen
Search grants from University of Texas Austin
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Clinical and Translational Research Training Program in Pulmonary Medicine
The Pink1-Parkin Pathway, Mitochondria and Parkinson's Disease
Identifying T Cell Ligands in Sarcoidosis
General Clinical Research Center
Surface Structure of Strongly Correlated Oxides
Recently added grants:
Drivers of MAPK-redundant resistance to BRAF inhibition in melanoma
Impact of TCR-pMHC affinity on prostate-specific CD4+ T cell development and function
Optimization and Investigation of Cruentaren A analogs
New approach for cholesterol and sphingolipid reduction in Niemann-Pick C1 disease
Random Field Modelling of Genetic and Epigenetic Association for Congenital Heart Defects in the Presence of Disease Heterogeneity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA073080-01
Application #
2011115
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1997-08-01
Project End
Budget Start
1997-02-01
Budget End
1998-01-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
University of Texas Austin
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
City
Austin
State
TX
Country
United States
Zip Code
78712
Related projects
NIH 1998
F32 CA
Synthesis of Pluramycin, an Antitumor Antibiotic Agent
Chen, Xinhai / University of Texas Austin
NIH 1997
F32 CA
Synthesis of Pluramycin, an Antitumor Antibiotic Agent
Chen, Xinhai / University of Texas Austin
Comments
Be the first to comment on Xinhai Chen's grant